JP2022542446A5 - - Google Patents
Info
- Publication number
- JP2022542446A5 JP2022542446A5 JP2022506466A JP2022506466A JP2022542446A5 JP 2022542446 A5 JP2022542446 A5 JP 2022542446A5 JP 2022506466 A JP2022506466 A JP 2022506466A JP 2022506466 A JP2022506466 A JP 2022506466A JP 2022542446 A5 JP2022542446 A5 JP 2022542446A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- hla class
- seq
- molecule according
- residue corresponding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962880496P | 2019-07-30 | 2019-07-30 | |
| US62/880,496 | 2019-07-30 | ||
| US202063029111P | 2020-05-22 | 2020-05-22 | |
| US63/029,111 | 2020-05-22 | ||
| PCT/IB2020/057175 WO2021019475A1 (en) | 2019-07-30 | 2020-07-29 | Mhc class ii molecules and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022542446A JP2022542446A (ja) | 2022-10-03 |
| JP2022542446A5 true JP2022542446A5 (enExample) | 2023-08-08 |
| JP7815101B2 JP7815101B2 (ja) | 2026-02-17 |
Family
ID=74230265
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022506466A Active JP7815101B2 (ja) | 2019-07-30 | 2020-07-29 | Ｍｈｃクラスｉｉ分子及びその使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220281948A1 (enExample) |
| EP (1) | EP4004032A4 (enExample) |
| JP (1) | JP7815101B2 (enExample) |
| KR (1) | KR20220052942A (enExample) |
| CN (1) | CN114450303B (enExample) |
| AU (1) | AU2020323767A1 (enExample) |
| BR (1) | BR112022001704A2 (enExample) |
| CA (1) | CA3146307A1 (enExample) |
| IL (1) | IL290225A (enExample) |
| MX (1) | MX2022001208A (enExample) |
| TW (1) | TWI881991B (enExample) |
| WO (1) | WO2021019475A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113795583B (zh) | 2019-03-04 | 2026-03-27 | 大学健康网络 | T细胞受体及其使用方法 |
| WO2021019473A1 (en) | 2019-07-30 | 2021-02-04 | University Health Network | Mhc class ii molecules and methods of use thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003111595A (ja) * | 2001-06-25 | 2003-04-15 | Kyogo Ito | 腫瘍抗原 |
| EP2657338B1 (en) * | 2005-01-25 | 2015-07-08 | NEC Corporation | HLA-binding peptide, and DNA fragment and recombinant vector coding for said HLA-binding peptide |
| PH12013501201A1 (en) | 2010-12-09 | 2013-07-29 | Univ Pennsylvania | Use of chimeric antigen receptor-modified t cells to treat cancer |
| EP3337822A1 (en) * | 2015-08-19 | 2018-06-27 | Rutgers, The State University of New Jersey | Novel methods of generating antibodies |
| WO2021019473A1 (en) * | 2019-07-30 | 2021-02-04 | University Health Network | Mhc class ii molecules and methods of use thereof |
| WO2021019476A1 (en) * | 2019-07-30 | 2021-02-04 | University Health Network | Methods of identifying t cell receptors |
| WO2021019474A1 (en) * | 2019-07-30 | 2021-02-04 | University Health Network | Mhc class ii molecules and methods of use thereof |
-
2020
- 2020-07-29 WO PCT/IB2020/057175 patent/WO2021019475A1/en not_active Ceased
- 2020-07-29 JP JP2022506466A patent/JP7815101B2/ja active Active
- 2020-07-29 EP EP20846795.1A patent/EP4004032A4/en active Pending
- 2020-07-29 CA CA3146307A patent/CA3146307A1/en active Pending
- 2020-07-29 MX MX2022001208A patent/MX2022001208A/es unknown
- 2020-07-29 BR BR112022001704A patent/BR112022001704A2/pt unknown
- 2020-07-29 AU AU2020323767A patent/AU2020323767A1/en active Pending
- 2020-07-29 KR KR1020227006941A patent/KR20220052942A/ko active Pending
- 2020-07-29 US US17/631,820 patent/US20220281948A1/en active Pending
- 2020-07-29 TW TW109125666A patent/TWI881991B/zh active
- 2020-07-29 CN CN202080068237.7A patent/CN114450303B/zh active Active
-
2022
- 2022-01-30 IL IL290225A patent/IL290225A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023059873A5 (enExample) | ||
| JP2023071729A5 (enExample) | ||
| JP2020529841A5 (enExample) | ||
| US20230241238A1 (en) | Bifunctional polypeptides | |
| Crocker et al. | Sialoadhesin, a macrophage sialic acid binding receptor for haemopoietic cells with 17 immunoglobulin‐like domains. | |
| JP2025065142A5 (enExample) | ||
| Westerlund et al. | The O75X adhesin of uropathogenic Escherichia coli is a type IV collagen‐binding protein | |
| JP2023504172A5 (enExample) | ||
| JP2019516665A5 (enExample) | ||
| SI1761553T1 (sl) | S tumorjem povezani peptidi, ki se veĹľejo na MHC molekule | |
| Pinilla et al. | Versatility of positional scanning synthetic combinatorial libraries for the identification of individual compounds | |
| JP2018171063A5 (enExample) | ||
| JPH06508638A (ja) | 変性ペプチド誘導体 | |
| JP2017070289A5 (enExample) | ||
| JP2020516314A5 (enExample) | ||
| JP2022537658A5 (enExample) | ||
| RU2009106710A (ru) | Слитый пептид, предназначенный для ингибирования взаимодействия нейронного nmda-рецептора (nmdar) с белками, взаимодействующими с nmdar | |
| JP2019530441A5 (enExample) | ||
| US20050089522A1 (en) | Methods of inhibiting osteoclastogenesis | |
| Takamiya et al. | HLA-B* 3501–peptide interactions: role of anchor residues of peptides in their binding to HLA-B* 3501 molecules | |
| Kim et al. | Molecular basis of HLA-C recognition by p58 natural killer cell inhibitory receptors | |
| CN112105720A (zh) | 一种基因工程化的免疫淋巴细胞及其制备方法 | |
| CN115776987A (zh) | 可条码化可交换肽-mhc多聚体文库 | |
| JP2023537070A5 (enExample) | ||
| JP2023510603A5 (enExample) |